月旦知識庫
 
  1. 熱門:
 
首頁 臺灣期刊   法律   公行政治   醫事相關   財經   社會學   教育   其他 大陸期刊   核心   重要期刊 DOI文章
婦癌醫學期刊 本站僅提供期刊文獻檢索。
  【月旦知識庫】是否收錄該篇全文,敬請【登入】查詢為準。
最新【購點活動】


篇名
女性生殖道惡性血管旁類上皮細胞瘤:北榮經驗以及系統性文獻回顧
並列篇名
Malignant perivascular epithelioid cell tumor in the female genital tract: Taipei VGH experience and systematic reviews
作者 劉家豪鄭敏趙偉廷林士傑劉希儒吳華席王鵬惠
中文摘要
惡性血管旁類上皮細胞瘤(perivascular epithelioid cell tumor, PEComa)為一種非常罕見之間質細胞腫瘤,可能從各種解剖學位置生長出來。文獻上婦女生殖道惡性血管旁類上皮細胞瘤一共有114例,其中最常見的好發位置是子宮(71.9%),其次是子宮頸(10.5%)。免疫學染色研究上,幾乎所有的女性生殖道惡性血管旁類上皮細胞瘤皆為HMB-45陽性(99.1%),超過半數為Desmin陽性(58.8%)。治療方面以完善減積手術(optimal debulking surgery)為主以及針對侵襲性的腫瘤給予口服mammalian target of rapamycin(mTOR)抑制劑,能夠延長disease-free survival(治癒率可達百分之五十至一百)。從2008年到2018年間,台北榮民總醫院婦女醫學部診斷治療了三例女性生殖道惡性血管旁類上皮細胞瘤個案,我們針對這3例北榮個案以及114個過去發表的個案做了詳細的分析以及文獻回顧。
英文摘要
Perivascular epithelioid cell tumor (PEComa) is a rare mesenchymal tumor, can arise from various anatomic sites. This study aimed to evaluate the clinic-pathological characteristics of patients with malignant PEComa arising from the female genital tract. A retrospective study was conducted in Taipei Veterans General Hospital (Taipei VGH) between 2008 and 2018. All published English cases based on the Preferred Reporting Items for Systematic Reviews and Meta- Analyses (PRISMA) statement were also included in the current review. A total of 114 women from PRISMA and 3 women from Taipei VGH were identified. The uterus was the most commonly involved site (82/114, 71.9%), followed by the cervix (12/114, 10.5%). Immunohistochemical staining showed that nearly all gynecological PEComas were positive for human melanoma black 45 (113/114, 99.1%). More than half of the gynecological PEComas were immune-reactive for desmin (50/85, 58.8%). Our results showed an optimal cytoreductive surgery, and mammalian target of rapamycin (mTOR) inhibitors for aggressive tumor behavior as targeted therapy, provided long-term disease-free survival (cure rate ranging from 50% to 100%, based on the different anatomic sites of the female genital tract). In conclusion, multi-modality treatment, including cytoreductive surgery and mTOR inhibitors with/without chemotherapy and/ or radiation, should be considered for the management of women with PEComas in the female genital tract with aggressive behavior.
起訖頁 31-38
刊名 婦癌醫學期刊  
期數 201910 (50期)
出版單位 台灣婦癌醫學會
該期刊-上一篇 北榮互愛支持團體
該期刊-下一篇 含胎兒腸道分化之分泌甲胎蛋白(AFP)之卵巢透明細胞腺癌:罕見案例報告及系統性文獻回顧
 

新書閱讀



最新影音


優惠活動




讀者服務專線:+886-2-23756688 傳真:+886-2-23318496
地址:臺北市館前路28 號 7 樓 客服信箱
Copyright © 元照出版 All rights reserved. 版權所有,禁止轉貼節錄